<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01375335</url>
  </required_header>
  <id_info>
    <org_study_id>1818</org_study_id>
    <nct_id>NCT01375335</nct_id>
  </id_info>
  <brief_title>The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement</brief_title>
  <official_title>The Effects of Dobutamine on Postoperative Systolic Deformation and Diastolic Function in Patients With Hypertrophic Cardiomyopathy Operated for Aortic Valve Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of dobutamine in postoperative hemodynamic treatment is widespread despite seemingly
      intact contraction of the heart. This study aims to elucidate the efficacy of low-dose
      dobutamine infusion in patients in the postoperative phase replacement of the aortic valve.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Insufficient patient eligible for recruitment
  </why_stopped>
  <start_date>June 2011</start_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>From 0 to 90 minutes after drug initiation</time_frame>
    <description>Change in cardiac output (l/min) from initiation of study drug or placebo until 90 minutes of infusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean pulmonary artery pressure</measure>
    <time_frame>From 0 to 90 minutes after drug initiation.</time_frame>
    <description>Changes in pulmonary artery pressure (mmHg) from start of study drug or placebo infusion until 90 minutes after the start.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography</measure>
    <time_frame>From 0 minutes to 90 minutes after drug initiation</time_frame>
    <description>Echocardiographic measures of systolic and diastolic heart function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in mixed venous saturation</measure>
    <time_frame>From 0 minutes to 90 minutes after drug initiation</time_frame>
    <description>Changes in mixed venous saturation (in per cent) from baseline until the end of dobutrex or placebo infusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>norepinephrine requirement</measure>
    <time_frame>From 0 minutes to 90 minutes after drug initiation</time_frame>
    <description>The amount of norepinephrinem(mg) required to maintain adequate systemic blood pressure during the infusion period of dobutrex and placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central venous pressure</measure>
    <time_frame>From 0 minutes to 90 minutes after drug initiation</time_frame>
    <description>Changes in CVP from baseline until 90 minutes of study drug or placebo infusion.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Dobutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dobutamine</intervention_name>
    <description>90 minutes of infusion 5 ug/kg/minute followed by isotonic saline for the same duration. The sequence of the above is randomized</description>
    <arm_group_label>Dobutamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-90 years

          -  Left ventricular posterior wall =/&gt;12mm

          -  Ejection fraction &gt; 45%

          -  Sinus rhythm

          -  Eligible for aortic valve replacement

        Exclusion Criteria:

          -  Need for concomitant cardiac bypass operation.

          -  Moderate or severe insufficiency of the mitral valve

          -  Active endocarditis

          -  Insufficient ultrasound window

          -  Using B-blockers

          -  Liver insufficiency

          -  Patients treated with COMT-inhibitors

          -  Allergy towards dobutamine

          -  Pregnancy

          -  Women of fertile age who do not use relevant anti-conception

          -  Lacking participant consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik Sloth, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesia &amp; Intensive Care, Århus Univerisity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesia &amp; Intensive Care, Århus University Hospital</name>
      <address>
        <city>Århus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2011</study_first_submitted>
  <study_first_submitted_qc>June 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2011</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative</keyword>
  <keyword>Dobutamine</keyword>
  <keyword>Inotropes</keyword>
  <keyword>Stunning</keyword>
  <keyword>Heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

